Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Neoadjuvant Herceptin in Patients With Breast Cancer

This study has been terminated.
(Study was closed to accrual as of 4/19/2006 / Study did not qualify for reporting.)
Genentech, Inc.
Information provided by (Responsible Party):
Baylor Breast Care Center Identifier:
First received: August 22, 2005
Last updated: March 22, 2013
Last verified: March 2013
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: April 2007
  Primary Completion Date: September 2005 (Final data collection date for primary outcome measure)